Combination therapy is a pillar of contemporary oncology, aimed at maximizing the treatment efficacy by employing more than one therapeutic modality simultaneously. The session "Combination Therapy" emphasizes strategies that incorporate chemotherapy, targeted therapy, immunotherapy, radiation, and new agents to achieve the best patient outcomes.".
Cancer cells may also become resistant to monotherapy, and tumor heterogeneity may lower therapy effectiveness. Through combination therapies with complementary mechanisms of action, multiple pathways can be targeted by clinicians, resistance overcome, and response rates enhanced. Combination regimens may also decrease the risk of recurrence and improve survival among individuals with advanced or aggressive cancers.
This session discusses evidence-based strategies for choosing and sequencing therapies, maximizing dosing schedules, and reducing toxicity. It also covers new research on new combinations, patient-tailored approaches informed by biomarkers, and adaptive protocols defined in response to individual patient profiles. Clinical trial experience provides insights into successes, challenges, and best practices in creating effective combination regimens.
Participants will learn about the principles, applications, and innovations of combination therapy. This session highlights how combining different treatment approaches can achieve more lasting responses, enhance quality of life, and promote personalized cancer care globally.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
